Neo Ivy Capital Management Buys 8,455 Shares of DaVita Inc. (NYSE:DVA)

Neo Ivy Capital Management boosted its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 191.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,879 shares of the company's stock after purchasing an additional 8,455 shares during the period. Neo Ivy Capital Management's holdings in DaVita were worth $1,926,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in DaVita by 14.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 466,046 shares of the company's stock worth $69,697,000 after buying an additional 57,386 shares in the last quarter. Worldquant Millennium Advisors LLC increased its holdings in shares of DaVita by 154.4% in the fourth quarter. Worldquant Millennium Advisors LLC now owns 95,372 shares of the company's stock valued at $14,263,000 after purchasing an additional 57,883 shares in the last quarter. Tidal Investments LLC raised its position in DaVita by 119.2% in the 4th quarter. Tidal Investments LLC now owns 12,466 shares of the company's stock worth $1,864,000 after purchasing an additional 6,778 shares during the last quarter. State of Wyoming lifted its holdings in DaVita by 59.6% during the 4th quarter. State of Wyoming now owns 2,020 shares of the company's stock worth $302,000 after buying an additional 754 shares in the last quarter. Finally, Siemens Fonds Invest GmbH acquired a new stake in shares of DaVita in the 4th quarter valued at $603,000. Institutional investors own 90.12% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Truist Financial cut their target price on shares of DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research report on Monday, May 19th. Barclays lifted their price target on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 18th. Cowen restated a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, DaVita currently has an average rating of "Hold" and an average target price of $164.50.

DaVita Trading Down 1.4%

Shares of NYSE:DVA traded down $2.00 during mid-day trading on Wednesday, reaching $137.90. The stock had a trading volume of 173,206 shares, compared to its average volume of 823,575. The firm has a market cap of $10.41 billion, a PE ratio of 12.84, a price-to-earnings-growth ratio of 1.07 and a beta of 1.14. The firm has a 50 day simple moving average of $144.90 and a two-hundred day simple moving average of $153.24. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a twelve month low of $131.76 and a twelve month high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.75 by $0.25. DaVita had a net margin of 7.31% and a return on equity of 115.48%. The company had revenue of $3.22 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same period last year, the firm posted $2.26 earnings per share. The business's quarterly revenue was up 5.0% compared to the same quarter last year. On average, research analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.